Topical cannabidiol (CBD) in skin pathology - A comprehensive review and prospects for new therapeutic opportunities.

Lehlohonolo Makhakhe

Journal: South African family practice : official journal of the South African Academy of Family Practice/Primary Care 2022;64(1):e1-e4

PMID: 35695447

Abstract

Humans have utilised cannabis products in various forms throughout the recorded history. To date, more than 500 biologically active components have been identified in the plants of the Cannabis genus, amongst which more than 100 were classified as phytocannabinoids (exocannabinoids). The plant genus Cannabis is a member of the plant family Cannabaceae, and there are three primary cannabis species which vary in their biochemical constituents: Cannabis sativa, Cannabis indica and Cannabis ruderalis. There has been a growing level of interest in research on the topical usage of a cannabis-based extract as a safer and more effective alternative to the usage of topical corticosteroids in treating some dermatoses. Together with the discovery of the cannabinoid receptors on the skin, it has been further illustrated that topical cannabis has anti-inflammatory, anti-itching, analgesics, wound healing and anti-proliferative effects on the skin.

Address: Department of Dermatology, Faculty of Health Science, University of the Free State, Bloemfontein, South Africa; and, The South African Institute of Dermatology, Bloemfontein. [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.